See also this year's filing and all EDGAR filings for this company.
PDF Report 0001802768_2023_Royalty_Pharma_plc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001802768, Royalty Pharma plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,554,908,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 14,258,558,000 |
| 4 | LiabilitiesCurrent | 1,166,783,000 |
| 5 | LiabilitiesNoncurrent | 6,121,310,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 227,303,000 |
| 9 | ResearchAndDevelopmentExpense | 177,106,000 |
| 10 | remainder_Expenses | 1,525,741,000 |
| 11 | remainder_Revenues | 2,237,215,000 |
| 12 | remainder_NetIncome | -77,001,000 |
| 13 | remainder_ComprehensiveNetIncome | -204,850,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,813,466,000 |
| 1 | Liabilities | 7,288,093,000 |
| 2 | Expenses | 1,930,150,000 |
| 3 | Revenues | 2,237,215,000 |
| 4 | StockholdersEquity | 9,525,373,000 |
| 5 | NetIncome | 230,064,000 |
| 6 | ComprehensiveNetIncome | 127,639,000 |
| 7 | BaseVar | 14,275,387,500 |
| 8 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
